Cargando…

Medicinal Cannabis and Central Nervous System Disorders

Cannabinoids, including those found in cannabis, have shown promise as potential therapeutics for numerous health issues, including pathological pain and diseases that produce an impact on neurological processing and function. Thus, cannabis use for medicinal purposes has become accepted by a growin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortiz, Yuma T., McMahon, Lance R., Wilkerson, Jenny L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070567/ https://www.ncbi.nlm.nih.gov/pubmed/35529444 http://dx.doi.org/10.3389/fphar.2022.881810

Ejemplares similares

Molecular imaging as a guide for the treatment of central nervous system disorders
por: Kim, Euitae, et al.
Publicado: (2013)

Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders
por: Hong, Hongxiang, et al.
Publicado: (2022)

A Review on Central Nervous System Effects of Gastrodin
por: Liu, Yuan, et al.
Publicado: (2018)

Editorial: Targeting Neuroinflammation in Central Nervous System Disorders: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
por: Pérez, Mariela Fernanda, et al.
Publicado: (2021)

Tolerance and dependence to Δ(9)-tetrahydrocannabinol in rhesus monkeys: Activity assessments
por: Wilkerson, Jenny L., et al.
Publicado: (2019)

Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
por: Cairns, Elizabeth A., et al.
Publicado: (2023)

Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis
por: Wu, Haiyang, et al.
Publicado: (2021)

Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis
por: Hazekamp, Arno
Publicado: (2016)

Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases
por: Gong, Liang, et al.
Publicado: (2022)

Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review
por: Liu, Yue, et al.
Publicado: (2022)

Axon growth inhibition by RhoA/ROCK in the central nervous system
por: Fujita, Yuki, et al.
Publicado: (2014)

The Case for TAAR1 as a Modulator of Central Nervous System Function
por: Rutigliano, Grazia, et al.
Publicado: (2018)

Role of TREK-1 in Health and Disease, Focus on the Central Nervous System
por: Djillani, Alaeddine, et al.
Publicado: (2019)

Mechanisms of Modulation of Ferroptosis and Its Role in Central Nervous System Diseases
por: Tan, Qingyun, et al.
Publicado: (2021)

The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review
por: Silva dos Santos, Jéssica, et al.
Publicado: (2021)

Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
por: German, Nadezhda A.
Publicado: (2023)

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years
por: MacPhail, Sara L., et al.
Publicado: (2022)

Unexpected loss of sensitivity to the nicotinic acetylcholine receptor antagonist activity of mecamylamine and dihydro‐β‐erythroidine in nicotine‐tolerant mice
por: de Moura, Fernando B., et al.
Publicado: (2020)

Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: Rationale and design of a prospective, multicenter, observational study
por: Liu, Jia, et al.
Publicado: (2022)

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
por: Pandey, Manisha, et al.
Publicado: (2022)

Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
por: Rodrigues, Márcio, et al.
Publicado: (2022)

Presynaptic Release-Regulating mGlu1 Receptors in Central Nervous System
por: Pittaluga, Anna
Publicado: (2016)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Neurological manifestations of oculodentodigital dysplasia: a Cx43 channelopathy of the central nervous system?
por: De Bock, Marijke, et al.
Publicado: (2013)

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System
por: Zhang, Haofuzi, et al.
Publicado: (2021)

Online survey of medicinal cannabis users: Qualitative analysis of patient-level data
por: Garcia-Romeu, Albert, et al.
Publicado: (2022)

Risks of harm with cannabinoids, cannabis, and cannabis-based medicine for pain management relevant to patients receiving pain treatment: protocol for an overview of systematic reviews
por: Gilron, Ian, et al.
Publicado: (2019)

Establishment of an Olfactory Region-specific Intranasal Delivery Technique in Mice to Target the Central Nervous System
por: Flamm, Johannes, et al.
Publicado: (2022)

Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
por: Liu, Shu-Ping, et al.
Publicado: (2022)

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
por: Flores, África, et al.
Publicado: (2013)

Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets
por: López, Víctor, et al.
Publicado: (2017)

Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
por: Lin, Guimiao, et al.
Publicado: (2017)

A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System
por: Chung, Yin-Sir, et al.
Publicado: (2020)

Overview of Cannabis including Kampo Medicine and Therapy for Treatment of Dementia: A Review
por: Wenger, Tibor, et al.
Publicado: (2022)

Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications
por: Brusa, Paola, et al.
Publicado: (2022)

Phytocannabinoids Profile in Medicinal Cannabis Oils: The Impact of Plant Varieties and Preparation Methods
por: Dei Cas, Michele, et al.
Publicado: (2020)

TRPM2 Channel in Microglia as a New Player in Neuroinflammation Associated With a Spectrum of Central Nervous System Pathologies
por: Malko, Philippa, et al.
Publicado: (2019)

Complementary and Alternative Medicine for the Treatment of Central Nervous System Disorders
por: Hsieh, Ching-Liang, et al.
Publicado: (2014)

Current challenges in regenerative medicine for central nervous system disorders
por: Ghanekar, Shaila, et al.
Publicado: (2016)

Visualizing the Potential Impairment of Polymyxin B to Central Nervous System Through MR Susceptibility-Weighted Imaging
por: Zhang, Ni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rju6urg06j5t638vcelc2ekqfc